Insider Transactions in Q4 2021 at Jazz Pharmaceuticals PLC (JAZZ)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2021
|
Jennifer E. Cook Director |
SELL
Open market or private sale
|
Direct |
417
-8.62%
|
$50,457
$121.3 P/Share
|
|
Dec 02
2021
|
Mark Douglas Smith Director |
SELL
Open market or private sale
|
Direct |
417
-8.62%
|
$50,457
$121.3 P/Share
|
|
Dec 01
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
6,748
-1.04%
|
$823,256
$122.72 P/Share
|
|
Dec 01
2021
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,700
+2.9%
|
$446,200
$46.83 P/Share
|
|
Nov 12
2021
|
Finbar Larkin SVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
197
-1.18%
|
$26,595
$135.79 P/Share
|
|
Nov 11
2021
|
Kim Sablich EVP, GM of U.S. |
SELL
Open market or private sale
|
Direct |
2,748
-11.51%
|
$370,980
$135.01 P/Share
|
|
Nov 01
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
6,556
-0.68%
|
$878,504
$134.64 P/Share
|
|
Nov 01
2021
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,700
+2.92%
|
$446,200
$46.83 P/Share
|
|
Oct 04
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
6,598
-2.07%
|
$851,142
$129.87 P/Share
|
|
Oct 04
2021
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,700
+2.95%
|
$446,200
$46.83 P/Share
|